This new investment strengthens the existing partnership between Syensqo Ventures and the Genesis Consortium, supporting startups in the SOSV’s IndieBio startup development program, the #1 early-stage biotech incubator.

“We see a growing demand for efficient and environmentally friendly solvents, which can also be biodegradable, non-toxic, and affordable. Bioeutetics’ cutting-edge technology is at the forefront of solvent innovation, combining high-performance, quality, and sustainability that could bring real added value to Syensqo’s portfolio of products,” commented Jean-Christophe Castaing, Global R&I Director, New Technologies at Syensqo.

Bioeutectics, founded in 2019, provides natural and high-performance solvents that make industrial products and processes more sustainable. Based on Natural Deep Eutectic Solvents (NADES), Bioeutetics mimics the way plants elaborate their solvents, using 100% renewable sources as opposed to petrochemical-based solvents. 

"We are excited to have Syensqo onboard to help us bring these early-stage innovations to the market. Syensqo’s expertise in solvents and formulation is key to our success,” said Tomas Silicaro, CEO of Bioeutectics.